Arm and Finger Measurement for Blood Pressure Surveillance (ARMFIN)

April 2, 2023 updated by: KK Women's and Children's Hospital
Accurate blood pressure (BP) measurement is critical in peripartum care. The cuff and bladder sizes affects the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC). However, evidence have shown the discrepancies between these sizes, leading to inaccuracy of BP measurement. This study will measure arm and finger size of 300 parturients in third trimester to determine whether the MAC, finger measurement or body mass index (BMI) is the best clinical predictor for non-standard cuff sizes for BP measurement.

Study Overview

Status

Active, not recruiting

Detailed Description

Accurate blood pressure (BP) measurement plays an important role in peripartum care as it is essential in detecting hypertensive disorders in pregnancy and medical decision making during the pregnancy. The cuff and bladder size have been highlighted as an important factor affecting the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC) assuming the arm is cylindrical in shape. However, evidence have shown a mismatch between these sizes, leading to BP overestimation or underestimation in obese patients. This is because the shape of the arm is a truncated cone instead of a cylinder, and the cuff will expand irregularly during inflation thus yielding inaccurate BP measurements. This is especially evident in Asian pregnant patients whereby no available guideline can recommend a suitable cuff for parturients with different MAC. Nexfin is a finger cuff device that can be a suitable alternative BP measurement device for such patients. In this study 300 parturients will be recruited in third trimester and undergoing nonemergent caesarean section in KKH. Patients' arm and finger sizes will be measured, and their user experience on current practices on BP measurement. The arm measurements will help to identify the proportion of women that may require non-standard cuff sizes for BP measurement. A conicity index will be determined whether the MAC, finger measurement or BMI is the best clinical predictor. The finger measurements will also help to determine the proportion of women that may require non-standard cuff sizes on the Nexfin device for BP measurement. The knowledge gathered in this pilot study will be used to design future studies in which the accuracy of Nexfin will be compared with standard BP measurement, which in turn will improve BP detection, subsequent patient monitoring and satisfaction.

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 229899
        • KK Women's and Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pregnant women in Singapore

Description

Inclusion Criteria:

  • American Society of Anaesthesiologists physical status 1 or 2 (ASA 1 or 2) parturients at 32 or more weeks of gestation
  • Multiparous or nulliparous;
  • Age 21-50 years old;
  • Undergoing Caesarean section in our institution.

Exclusion Criteria:

  • Emergent Caesarean section such that consent and measurements cannot be taken.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant cohort
Parturients of gestational age >= 32 weeks will have measurements of arm length, MAC, proximal arm circumference, distal arm circumference, finger circumference to generate the conicity index.
Parturients of gestational week >= 32 weeks will have their arms and fingers measured to generate the conicity index.
Other Names:
  • Measurement of fingers and arms
Fit on arm cuff and finger cuff as selected by investigators based on the measurement.
Other Names:
  • Cuff fitting for arm and finger

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arm length (Left, Right)
Time Frame: During antenatal visit (1-2 hours). One visit only
The distance (cm) between the tip of the acromion process to the tip of the olecranon process on the posterior aspect of the arm, with the elbow in the flexed position.
During antenatal visit (1-2 hours). One visit only
Mid Arm circumference (MAC)(Left, Right)
Time Frame: During antenatal visit (1-2 hours). One visit only
The circumference (cm) of the arm at the mid-point of the arm length as measured above, with the arm hanging by the side.
During antenatal visit (1-2 hours). One visit only

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proximal arm circumference (Left, Right)
Time Frame: During antenatal visit (1-2 hours). One visit only
Arm circumference (cm) of the arm measured at the axilla, with the arm hanging by the side.
During antenatal visit (1-2 hours). One visit only
Distal arm circumference (Left, Right)
Time Frame: During antenatal visit (1-2 hours). One visit only
The circumference (cm) at the elbow above the elbow crease, with the arm hanging by the side.
During antenatal visit (1-2 hours). One visit only
Finger circumference (Left, Right)
Time Frame: During antenatal visit (1-2 hours). One visit only
The circumference (cm) of the mid-point of the middle phalanx of the middle finger will be measured with the hands placed flat on a table.
During antenatal visit (1-2 hours). One visit only
Feedback on experiences of previous BP measurement
Time Frame: During antenatal visit (1-2 hours). One visit only
Participants will also respond to a three-point rating scale (Never, sometimes, always) about their experience of the procedures for previous BP measurement during the current pregnancy, with questions such as the length of time taken to obtain a reading, the need to change a cuff when taking BP, the need to take BP on the leg and whether the arm felt uncomfortable when taking blood pressure.
During antenatal visit (1-2 hours). One visit only

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Farida Ithnin, MMED (Anaes), KK Women's and Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2019

Primary Completion (Actual)

December 11, 2019

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

May 27, 2019

First Submitted That Met QC Criteria

July 4, 2019

First Posted (Actual)

July 9, 2019

Study Record Updates

Last Update Posted (Actual)

April 4, 2023

Last Update Submitted That Met QC Criteria

April 2, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ARMFIN
  • ANAESPRG19/012 (Other Identifier: SingHealth ANAES ACP)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension, Pregnancy-Induced

Clinical Trials on Physical measurement

3
Subscribe